Fundraising Fox
🦊/People
Sign in

Nick Sireau

Founder

Executive Chairman & Co-founder at Serenatis Bio

Greater Cambridge Area

FoundedSerenatis Bio

Find your path to Nick

308 people in our graph share verified history with Nick — schools, employers, funds. One of them is your warm intro.

Detlev BiniszkiewiczunlockedNick: together at AstraZeneca (2015)
×2Nick: together at AstraZeneca
×8Nick: together at City University
Nick: together at University of Westminster

About

Nick Sireau is Co-founder and Executive Chairman of Serenatis Bio, a Cambridge-based biotech developing mechanism-led treatments for obsessive-compulsive disorder and other disorders of compulsivity, with a focus on precision psychiatry, compulsivity circuits, and glutamate, dopamine and neuro-inflammatory biology. He is also Co-founder and Trustee of Orchard OCD, a non-profit dedicated to OCD research. Previously, he led the AKU Society's development of nitisinone for alkaptonuria, advancing the treatment through phase 2 and phase 3 clinical trials to regulatory approval.

Executive Chairman & Co-founder at Serenatis Bio

Intro paths

→

In turn, Nick can intro founders to Serenatis Bio's investors below.

Serenatis Bio's investors · 2

P53 InvestStavangerZincLondon

Co-founders at Serenatis Bio

DCDavid Cavalla
David CavallaCEO & Co-founder

Experience

  1. Serenatis BioCo-founder and Executive Chairmancurrent2024 — presentCambridge
  2. Orchard OCDFounder and Trusteecurrent2017 — presentCambridge, United Kingdom
  3. AKU SocietyDirector and Trusteecurrent2003 — presentUK, Cambridge
  4. Sireau LabsCo-founder and Director2022 — 2025Cambridge, England, United Kingdom
  5. Beacon for Rare DiseasesCo-founder and Chair2012 — 2024UK, Cambridge
  6. Cambridge Rare Disease NetworkBoard Trustee2014 — 2017Cambridge, United Kingdom
  7. SolarAidCEO2016London, United Kingdom
  8. AstraZenecaPatient Engagement Director (Oncology)2015 — 2016Cambridge, United Kingdom
  9. SolarAidCEO2006 — 2010UK and Africa
  10. ProgressioDirector of Communications2003 — 2006UK, Africa, Asia and Latin America
  11. CWMInformation Officer1998 — 2003UK and worldwide
  12. Bridge NewsFinancial Reporter1998UK, Fleet Street
  13. Independent Economic AnalysisNew Media Writer1996 — 1998UK, London

Skills & more

Social Entrepreneurship76FundraisingInternational Development55Rare Diseases7Social Enterprise23Research37Social Media8Project Management3NGOs26Non-profits5Corporate Social Responsibility13Media Relations30
+12 moreCharitiesEntrepreneurshipVolunteer ManagementBiotechnologyNonprofitsBusiness StrategyStrategic CommunicationsPublic RelationsStrategic PlanningStrategyPublic SpeakingLeadership

Languages English · French · Spanish

  • nextGEN Member at LifeScience ORG — LifeScience ORG

From Nick's professional profile.

Frequently asked questions

Who is Nick Sireau?
Nick Sireau is Co-founder and Executive Chairman of Serenatis Bio, a Cambridge-based biotech developing mechanism-led treatments for obsessive-compulsive disorder and other disorders of compulsivity, with a focus on precision psychiatry, compulsivity circuits, and glutamate, dopamine and neuro-inflammatory biology. He is also Co-founder and Trustee of Orchard OCD, a non-profit dedicated to OCD research. Previously, he led the AKU Society's development of nitisinone for alkaptonuria, advancing the treatment through phase 2 and phase 3 clinical trials to regulatory approval.
Where does Nick Sireau work?
Nick Sireau is Executive Chairman & Co-founder of Serenatis Bio.
What companies did Nick Sireau found?
Nick Sireau founded Serenatis Bio.
Where did Nick Sireau go to school?
Nick Sireau studied at Hertford College, Oxford University (MA (Oxon), History and Economics); Lyon Graduate School of Business (Master of Science (MSc), Business Studies); University of Westminster (Master of Arts (MA), Journalism Studies).

Founder mafias

Same school

Shared employers